SPX (SPXC) Getting Somewhat Positive News Coverage, Accern Reports

News stories about SPX (NYSE:SPXC) have been trending somewhat positive on Monday, Accern reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. SPX earned a news impact score of 0.12 on Accern’s scale. Accern also assigned headlines about the company an impact score of 44.6529373396518 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Several research analysts recently issued reports on SPXC shares. BidaskClub raised SPX from a “sell” rating to a “hold” rating in a research note on Tuesday, September 12th. Zacks Investment Research cut SPX from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. UBS Group increased their price objective on SPX from $36.00 to $39.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. TheStreet raised SPX from a “d+” rating to a “c” rating in a research note on Monday, November 6th. Finally, ValuEngine lowered SPX from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 14th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $37.00.

Shares of SPX (NYSE:SPXC) opened at $31.39 on Monday. The company has a current ratio of 1.15, a quick ratio of 0.81 and a debt-to-equity ratio of 1.22. The firm has a market capitalization of $1,337.50, a price-to-earnings ratio of -23.08 and a beta of 1.72. SPX has a twelve month low of $21.97 and a twelve month high of $32.71.

SPX (NYSE:SPXC) last posted its earnings results on Thursday, November 2nd. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.08. The company had revenue of $348.50 million during the quarter, compared to analyst estimates of $343.12 million. SPX had a positive return on equity of 37.49% and a negative net margin of 3.86%. SPX’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.14 earnings per share. equities analysts forecast that SPX will post 1.8 EPS for the current year.

In other SPX news, CAO Michael Andrew Reilly sold 3,833 shares of the company’s stock in a transaction on Friday, November 10th. The stock was sold at an average price of $30.59, for a total transaction of $117,251.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.55% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This story was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.com-unik.info/2018/01/01/spx-spxc-getting-somewhat-positive-news-coverage-accern-reports.html.

SPX Company Profile

SPX Corporation is a global supplier of infrastructure equipment. The Company operates through three segments: HVAC; Detection and Measurement, and Engineered Solutions. The HVAC solutions offered by its businesses include package cooling towers, residential and commercial boilers, heating and ventilation products.

Insider Buying and Selling by Quarter for SPX (NYSE:SPXC)

What are top analysts saying about SPX? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for SPX and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit